Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of FeNO During and Following Acute COPD Exacerbation

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age: 40 years and above, inclusive~* Sex: Males and Females~* Smoking History: ≥20 pack years.~* COPD Defined as an FEV1/ FVC or FEV1/SVC ratio \<70% predicted.~* AECOPD defined as a clinically significant worsening of COPD symptoms requiring treatment with antibiotics and/or systemic steroids and/or hospitalization for same.~Exclusion Criteria:~* Use of Systemic Corticosteroids for more than 48 hours prior to Visit 1.~* AECOPD requiring mechanical ventilation~* Study Participation Outside of This Protocol: Patients currently enrolled in studies of Investigational or non-Investigational Drugs or Medical Devices and/or who participated in these studies within 30 days prior to this study are excluded.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).